Cell Therapy Potency Assay Summit, taking place from 25-27 of July in Boston, will bring together professionals working in analytical development, quality, regulatory and process development functions. Join your peers to: Brainstorm best-in-class approaches to overcome variability in QC Compare next gen approaches from cytotoxicity to omics Develop reference standards to benchmark across the industry […]

The data has dropped and 2022 has been touted as a monumental year for γδT Therapies With Adicet Bio, In8Bio, Gamma Delta Therapeutics, Lava Therapeutics, and ImCheck Therapeutics releasing clinical data from engineered and antibody-based γδT Therapy in patients; the race to market for the first allogeneic and solid tumor-targeting γδT Therapy is truly on. […]

The 3rd Annual B & T Cell-Mediated Autoimmune Disease Drug Development Summit is the only industry-led forum focused on the therapeutic opportunity of drugs directed against B-cell, plasma cell, and T-cell targets in autoimmunity. Several drug approvals for B-cell directed therapies have made waves in autoimmune drug development. As investment and industry momentum increases, this […]

The 3rd Cytokine-Based Drug Development Summit has been developed following extensive research to address YOUR biggest challenges in the cytokine field. With 30+ expert speakers, including the hottest academic researchers and leading figures from the industry, this 4-day program is your opportunity to gain insight into the latest clinical advancement and have thought provoking discussions around how to overcome the […]

Do you want to be part of the largest gathering of mRNA professionals? The 2nd Annual mRNA-Based Therapeutics Summit is returning in-person to Boston this July 26-28. Expect exclusive data from the movers and shakers in mRNA vaccine and therapy development, 75+ world-class speakers, 5 dedicated tracks of content and 45+ deep-dive case studies. Find out more in the full event guide: https://ter.li/yc800m Here’s a snapshot of the expert speakers […]

With iPSCs exhibiting game-changing potential in the bid to develop an off-the-shelf therapy, the brand-new iPSC Manufacturing Summit is the only summit dedicated to solving the manufacturing, quality and analytical challenges hindering your iPSC-derived treatments from reaching patients. This forum will unite the exclusive community advancing the production of high-quality and consistent iPSC products, with in depth […]

The brand-new Targeted Radiopharmaceuticals Summit US (TRP US) is the only industry-led meeting dedicated to developing next-generation radioligands. The TRP sector has developed dramatically over the previous 18 months, with a wave of new investment in light of Lutathera’s extraordinary performance. Are you part of a pharmaceutical business aiming to have their Theranostic approved? If […]